Metraipolis › archive › dc_88f5adfa2cc4

Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework — Europe PMC PMID:41644572

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41644572
DOI
10.1038/s41541-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-06T02:34:53.738Z
SHA-256 of the archived text
6d7637650e909ca0d8a06847c2c02baa043b83ba37139b974e416d1d92422eaa
Stable URL of this page
https://metraipolis.com/documento/dc_88f5adfa2cc4

How to cite

Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework — Europe PMC PMID:41644572 — Europe PMC (en), https://europepmc.org/article/MED/41644572 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_88f5adfa2cc4 (Metraipolis archive dc_88f5adfa2cc4, sha256 6d7637650e909ca0d8a06847c2c02baa043b83ba37139b974e416d1d92422eaa)
BibTeX
@misc{dc88f5adfa2cc4,
  title = {Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework — Europe PMC PMID:41644572},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41644572},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_88f5adfa2cc4; sha256 6d7637650e909ca0d8a06847c2c02baa043b83ba37139b974e416d1d92422eaa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41644572. Agents can read the archived copy with the MCP tool read_document.